UCSF Steps Up Biobanking Program Efforts, Naming Its First Chief Biobank Officer

Analysts predict that the global tissue banking market will grow to nearly $3 billion by 2026. Health executives at UCSF have recognized this trend and are executing on plan to attract patients and funding, and ultimately improve outcomes...
Read More

Hospital CEOs: McKinsey says "Hospitals Are Dead. Long Live the Hospital"

Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in...
Read More

Independent and Rural Hospitals Closing at Record Rates, Vulnerable Patients at Risk of Missing Out on Precision Medicine's Potential

Studies by KHN, Navigant, and others report that independent rural hospitals are closing at record rates, leaving patients without critical nearby healthcare services, including precision medicine’s benefits...
Read More

Answer These Questions Before Embarking on a Precision Medicine Journey

Temple University All of Us lead investigators discuss the clinical and business reasons and community impact of joining the NIH precision medicine research project...
Read More

Do Multigene Panels Offer Cancer Patients, Payers More Value?

Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer....
Read More

Why the Cleveland Clinic Uses Telegenetics, Chatbots to Address Genetic Cancer Risk

Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics...
Read More

Bridging the Gap Between the Clinical Possibilities and Economics of Precision Medicine

From research and development to pricing and access, the discourse on precision medicine is expanding, reflecting the emergence of new and multiple ideas of precision medicine aims in relation to healthcare economics, payment models, and patient outcomes...
Read More

Considering Risks and Privacy in Genetic Medicine: Q&A with Dr. Paul S. Appelbaum

Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information...
Read More

How Healthcare Organizations Can Drive Diversity in Genetic Research

Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs...
Read More